VTYX NASDAQ
Ventyx Biosciences, Inc.
1W: +0.2%
1M: +0.7%
3M: +78.6%
YTD: +66.7%
1Y: +821.0%
3Y: -68.5%
$14.00
Last traded 2026-03-06 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
7 relationships7
As Filer
counterparties named
0
As Counterparty
mentioned by others
4
Rel. Types
2022-12-20
Earliest Filing
2026-03-04
Latest Filing
acquirer: 3
partner: 2
investor: 1
customer: 1
Counterparties (Filed by VTYX)
7 relationshipsCompanies named in VTYX's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Eli Lilly and Company | LLY | acquirer | Acquired Ventyx Biosciences, Inc. in a merger transaction consummated on March 4, 2026. | 2026-03-04 | View |
| Eli Lilly and Company | LLY | acquirer | Parent company acquiring Ventyx Biosciences, Inc. in a merger transaction. | 2026-01-07 | View |
| RYLS Merger Corporation | — | acquirer | Wholly owned subsidiary of Eli Lilly and Company used as the merger vehicle. | 2026-01-07 | View |
| Aventis Inc. | — | investor | Investor in private placement for Series A Non-Voting Convertible Preferred Stock | 2024-09-23 | View |
| Sanofi | SNYNF | partner | Granted right of first negotiation (ROFN) for license or transfer of VTX3232 rights | 2024-09-23 | View |
| Neurocrine Biosciences, Inc. | NEO | customer | Sublessee of approximately 35,016 rentable square feet for Ventyx Biosciences' new corporate headquarters. | 2023-07-26 | View |
| Jefferies LLC | JEF | partner | Entered into an Open Market Sale Agreement to act as agent or principal for the sale of the Company's common stock. | 2022-12-20 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-03-04 | Completion of Acquisition or Disposition of Assets; Notice of Delisting or Transfer; Material Modifi | Acquisition | View |
| 2026-03-03 | Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits | View | |
| 2026-02-23 | Other Events | View | |
| 2026-01-22 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2026-01-07 | Entry into Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibit | Agreement | View |
| 2025-11-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-10-22 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-08-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-06-17 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-06-10 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-08 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-02-27 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-01-14 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2024-11-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-09-23 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Amendments to Art | Agreement | View |
| 2024-08-30 | Departure/Election of Directors; Appointment of Officers | View | |
| 2024-08-08 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-06-06 | Submission of Matters to a Vote of Security Holders | View | |
| 2024-06-05 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2024-05-16 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR